Rajan Wadhawan
Brown University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rajan Wadhawan.
Journal of Perinatology | 2015
An N. Massaro; Karna Murthy; Isabella Zaniletti; Noah Cook; Robert DiGeronimo; Maria L.V. Dizon; Shannon E. G. Hamrick; Victor J. McKay; Girija Natarajan; Rakesh Rao; Danielle Smith; R. Telesco; Rajan Wadhawan; Jeanette M. Asselin; David J. Durand; Jacquelyn Evans; Francine D. Dykes; Kristina M. Reber; Michael A. Padula; Eugenia K. Pallotto; Billie L. Short; Amit Mathur
Objective:To characterize infants affected with perinatal hypoxic ischemic encephalopathy (HIE) who were referred to regional neonatal intensive care units (NICUs) and their related short-term outcomes.Study Design:This is a descriptive study evaluating the data collected prospectively in the Children’s Hospital Neonatal Database, comprised of 27 regional NICUs within their associated children’s hospitals. A consecutive sample of 945 referred infants born ⩾36 weeks’ gestation with perinatal HIE in the first 3 days of life over approximately 3 years (2010–July 2013) were included. Maternal and infant characteristics are described. Short-term outcomes were evaluated including medical comorbidities, mortality and status of survivors at discharge.Result:High relative frequencies of maternal predisposing conditions, cesarean and operative vaginal deliveries were observed. Low Apgar scores, profound metabolic acidosis, extensive resuscitation in the delivery room, clinical and electroencephalographic (EEG) seizures, abnormal EEG background and brain imaging directly correlated with the severity of HIE. Therapeutic hypothermia was provided to 85% of infants, 15% of whom were classified as having mild HIE. Electrographic seizures were observed in 26% of the infants. Rates of complications and morbidities were similar to those reported in prior clinical trials and overall mortality was 15%.Conclusion:Within this large contemporary cohort of newborns with perinatal HIE, the application of therapeutic hypothermia and associated neurodiagnostic studies appear to have expanded relative to reported clinical trials. Although seizure incidence and mortality were lower compared with those reported in the trials, it is unclear whether this represented improved outcomes or therapeutic drift with the treatment of milder disease.
The Journal of Pediatrics | 2016
An N. Massaro; Karna Murthy; Isabella Zaniletti; Noah Cook; Robert DiGeronimo; Maria L.V. Dizon; Shannon E. G. Hamrick; Victor J. McKay; Girija Natarajan; Rakesh Rao; Troy Richardson; Danielle Smith; Amit Mathur; Francine D. Dykes; Anthony J. Piazza; Gregory Sysyn; Carl Coghill; Ramasubbareddy Dhanireddy; Anne Hansen; Tanzeema Hossain; Kristina M. Reber; Rashmin C. Savani; Luc P. Brion; Theresa R. Grover; Annie Chi; Yvette R. Johnson; Gautham Suresh; Eugenia K. Pallotto; Becky Rodgers; Robert Lyle
OBJECTIVE To quantify intercenter cost variation for perinatal hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia across childrens hospitals. STUDY DESIGN Prospectively collected data from the Childrens Hospitals Neonatal Database and Pediatric Health Information Systems were linked to evaluate intercenter cost variation in total hospitalization costs after adjusting for HIE severity, mortality, length of stay, use of extracorporeal support or nitric oxide, and ventilator days. Secondarily, costs for intensive care unit bed, electroencephalography (EEG), and laboratory and neuroimaging testing were also evaluated. Costs were contextualized by frequency of favorable (survival with normal magnetic resonance imaging) and adverse (death or need for gastric tube feedings at discharge) outcomes to identify centers with relative low costs and favorable outcomes. RESULTS Of the 822 infants with HIE treated with therapeutic hypothermia at 19 regional neonatal intensive care units, 704 (86%) survived to discharge. The median cost/case for survivors was
The Journal of Pediatrics | 2018
Hussnain Mirza; Jorge A. Garcia; Elizabeth Crawford; Julie Pepe; Matthew Zussman; Rajan Wadhawan; William Oh
58 552 (IQR
American Journal of Physiology-heart and Circulatory Physiology | 2005
Yi-Tang Tseng; Naohiro Yano; Adam Rojan; Joan P. Stabila; Bethany McGonnigal; Vlad Ianus; Rajan Wadhawan; James F. Padbury
32 476-
Journal of Perinatology | 2014
Karna Murthy; Rashmin C. Savani; Joanne Lagatta; Isabella Zaniletti; Rajan Wadhawan; William E. Truog; Theresa R. Grover; Huayan Zhang; Jeanette M. Asselin; David J. Durand; Billie L. Short; Eugenia K. Pallotto; Michael A. Padula; Francine D. Dykes; Kristina M. Reber; Jacquelyn Evans
130 203) and nonsurvivors
Journal of Pediatric Surgery | 2014
Karna Murthy; Jacquelyn Evans; Amina M. Bhatia; David H. Rothstein; Rajan Wadhawan; Isabella Zaniletti; Rakesh Rao; Cary Thurm; Amit Mathur; Anthony J. Piazza; James E. Stein; Kristina M. Reber; Billie L. Short; Michael A. Padula; David J. Durand; Jeanette M. Asselin; Eugenia K. Pallotto; Francine D. Dykes
29 760 (IQR
The Journal of Pediatrics | 2017
Roberta L. Keller; Eric C. Eichenwald; Anna Maria Hibbs; Elizabeth E. Rogers; Katherine C. Wai; Dennis M. Black; Philip L. Ballard; Jeanette M. Asselin; William E. Truog; Jeffrey D. Merrill; Mark C. Mammel; Robin H. Steinhorn; Rita M. Ryan; David J. Durand; Catherine M. Bendel; Ellen M. Bendel-Stenzel; Sherry E. Courtney; Ramasubbareddy Dhanireddy; Mark L. Hudak; Frances R. Koch; Dennis E. Mayock; Victor J. McKay; Jennifer Helderman; Nicolas Porta; Rajan Wadhawan; Lisa Palermo; Roberta A. Ballard
16 897-
The Journal of Allergy and Clinical Immunology | 2002
Yi-Tang Tseng; Rajan Wadhawan; Joan P. Stabila; Bethany McGonnigal; James F. Padbury
61 399). Adjusting for illness severity and select interventions, intercenter differences explained 29% of the variation in total hospitalization costs. The widest cost variability across centers was EEG use, although low cost and favorable outcome centers ranked higher with regards to EEG costs. CONCLUSIONS There is marked intercenter cost variation associated with treating HIE across regional childrens hospitals. Our investigation may help establish references for cost and enhance quality improvement and resource utilization projects related to HIE.
American Journal of Physiology-heart and Circulatory Physiology | 2003
Rajan Wadhawan; Yi-Tang Tseng; Joan P. Stabila; Bethany McGonnigal; Sumita Sarkar; James F. Padbury
Objective To study the natural history of postnatal cardiopulmonary adaptation in infants born extremely preterm and establish its association with death or bronchopulmonary dysplasia (BPD). Study design This was a prospective, observational, cohort study of infants born extremely preterm (<29 weeks). Initial echocardiogram was performed at <48 hours of life, followed by serial echocardiograms every 24‐48 hours until 14 days of life. Resolution or no resolution of pulmonary hypertension (PH) at 72‐96 hours was considered normal or delayed postnatal cardiopulmonary adaptation, respectively. PH between 96 hours and 14 days was defined as subsequent PH. Elevated pulmonary artery pressure throughout the 14 days of life was considered persistent PH. BPD was assessed at 36 weeks of postmenstrual age. Results Sixty infants were enrolled; 2 died before a sequential echocardiogram could be done at 72‐96 hours. Normal and delayed cardiopulmonary adaptation were noted in 26 (45%) and 32 (55%) infants, respectively. Five patterns of postnatal cardiopulmonary adaptation were recognized: normal without subsequent PH (n = 20), normal with subsequent PH (n = 6), delayed adaptation without subsequent PH (n = 6), delayed adaptation with subsequent PH (n = 16), and persistent PH (n = 10). Infants with delayed cardiopulmonary adaptation were of lower gestation and birth weight and required prolonged ventilation and supplemental oxygen (P < .05). On multivariate analysis, the incidence of death or BPD was significantly greater among infants with delayed adaptation (P < .001). Conclusion Infants born extremely preterm have normal or delayed postnatal cardiopulmonary adaptation that can be complicated by subsequent or persistent PH. Delayed cardiopulmonary adaptation is associated independently with death or BPD.
The Journal of Pediatrics | 2002
Rajan Wadhawan; Lewis P. Rubin